Cuorips Inc banner
C

Cuorips Inc
TSE:4894

Watchlist Manager
Cuorips Inc
TSE:4894
Watchlist
Price: 8 080 JPY 6.32% Market Closed
Market Cap: ¥66.7B

Cuorips Inc
Investor Relations

Cuorips Inc is a Japan-based company mainly engaged in the development and commercialization of regenerative medical products and contract development and manufacturing organization (CDMO) business. The company is headquartered in Chuo-Ku, Tokyo-To and currently employs 46 full-time employees. The company went IPO on 2023-06-27. The main product of the Company is human iPS cell-derived cardiomyocyte sheets. The firm provides regenerative medical products for the heart and other areas through in-house research, joint research with universities and other research institutions and major pharmaceutical companies. The firm operates CDMO business using CLiC-1, a commercial cell culture and processing facility with an integrated laboratory based on the Company's original design concept.

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
No Earnings Calls Available

Management

Takayuki Kusanagi
President, CEO & Director
No Bio Available
Taichi Kobayashi
Chief Financial Officer
No Bio Available
Yoshiki Sawa
CTO & Director
No Bio Available
Tadayuki Tanimura
Executive Vice President
No Bio Available

Contacts

Address
TOKYO-TO
Chuo-Ku
507, Nihonbashi Life Science Bldg. 2, 3-11-5, Nihonbashi Hon-cho
Contacts
+81362310043
cuorips.co.jp
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett